Topics

Articles

Previous merger earns clinical research company $235 million as it looks to advance patient enrollment 

Company officials believe new facility will help meet ongoing demand for temperature-controlled packaging

Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization 

Manufacturing facility to provide 1.5 million square feet of bioproduction technologies 

Will feature laboratories intended for R&D

Collaboration centers around providing assistance to multiple links in the clinical trial chain, from participants to providers

Development of additional 29,000 square feet addresses med tech company’s internal production capabilities 

Recent FDA actions may finally usher in access boost to follow-on biologics in the US 

R&D partnership with VaxEquity outlines plan to use saRNA as a go-to therapeutic

Availability of space for new labs is a key selling point